SIMILAR PATTERNS OF AMINO ACIDS FOR 3OXZ_A_0LIA1_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1k2p | TYROSINE-PROTEINKINASE BTK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 428LEU A 457VAL A 458THR A 474GLY A 480HIS A 519 | None | 0.69A | 3oxzA-1k2pA:28.6 | 3oxzA-1k2pA:45.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1k9a | CARBOXYL-TERMINALSRC KINASE (Rattusnorvegicus) |
PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 8 | ALA A 220GLU A 236MET A 240LEU A 248VAL A 249THR A 266GLY A 272HIS A 312 | None | 0.54A | 3oxzA-1k9aA:31.3 | 3oxzA-1k9aA:31.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1k9a | CARBOXYL-TERMINALSRC KINASE (Rattusnorvegicus) |
PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 7 | GLU A 236MET A 240LEU A 248VAL A 249THR A 266HIS A 312ASP A 332 | None | 1.15A | 3oxzA-1k9aA:31.3 | 3oxzA-1k9aA:31.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1luf | MUSCLE-SPECIFICTYROSINE KINASERECEPTOR MUSK (Rattusnorvegicus) |
PF07714(Pkinase_Tyr) | 6 | ALA A 606VAL A 638GLY A 660HIS A 722ALA A 741ASP A 742 | None | 0.69A | 3oxzA-1lufA:33.7 | 3oxzA-1lufA:36.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1opk | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 (Mus musculus) |
PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 9 | ALA A 288GLU A 305MET A 309ILE A 312LEU A 317THR A 334GLY A 340HIS A 380ALA A 399 | P16 A 2 (-3.4A)P16 A 2 (-4.2A)P16 A 2 (-3.3A)NoneNoneP16 A 2 (-3.7A)P16 A 2 (-3.4A)NoneP16 A 2 (-3.5A) | 0.52A | 3oxzA-1opkA:34.6 | 3oxzA-1opkA:57.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1opk | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 (Mus musculus) |
PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 9 | ALA A 288GLU A 305MET A 309ILE A 312LEU A 317VAL A 318THR A 334GLY A 340HIS A 380 | P16 A 2 (-3.4A)P16 A 2 (-4.2A)P16 A 2 (-3.3A)NoneNoneP16 A 2 ( 4.7A)P16 A 2 (-3.7A)P16 A 2 (-3.4A)None | 0.50A | 3oxzA-1opkA:34.6 | 3oxzA-1opkA:57.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1rjb | FL CYTOKINE RECEPTOR (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 642GLU A 661VAL A 675GLY A 697HIS A 809ASP A 829 | None | 0.72A | 3oxzA-1rjbA:31.7 | 3oxzA-1rjbA:37.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1snx | TYROSINE-PROTEINKINASE ITK/TSK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 389MET A 410LEU A 418VAL A 419GLY A 441HIS A 480 | None | 0.82A | 3oxzA-1snxA:22.4 | 3oxzA-1snxA:40.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1t46 | HOMO SAPIENS V-KITHARDY-ZUCKERMAN 4FELINE SARCOMA VIRALONCOGENE HOMOLOG (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 621GLU A 640GLY A 676HIS A 790ASP A 810PHE A 811 | STI A 3 (-3.5A)STI A 3 (-3.6A)STI A 3 ( 3.8A)STI A 3 (-4.5A)STI A 3 (-3.9A)STI A 3 (-3.6A) | 0.87A | 3oxzA-1t46A:33.1 | 3oxzA-1t46A:36.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1t46 | HOMO SAPIENS V-KITHARDY-ZUCKERMAN 4FELINE SARCOMA VIRALONCOGENE HOMOLOG (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 621GLU A 640VAL A 654THR A 670GLY A 676HIS A 790ASP A 810 | STI A 3 (-3.5A)STI A 3 (-3.6A)STI A 3 (-4.3A)STI A 3 (-3.2A)STI A 3 ( 3.8A)STI A 3 (-4.5A)STI A 3 (-3.9A) | 0.35A | 3oxzA-1t46A:33.1 | 3oxzA-1t46A:36.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1u59 | TYROSINE-PROTEINKINASE ZAP-70 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 367GLU A 386MET A 390VAL A 399GLY A 420HIS A 459 | STU A 100 (-3.2A)NoneNoneNoneSTU A 100 (-3.5A)None | 0.71A | 3oxzA-1u59A:31.5 | 3oxzA-1u59A:38.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2dq7 | PROTO-ONCOGENETYROSINE-PROTEINKINASE FYN (Homo sapiens) |
PF07714(Pkinase_Tyr) | 9 | ALA X 37GLU X 54MET X 58LEU X 66VAL X 67THR X 82GLY X 88HIS X 128ALA X 147 | STU X 902 (-3.1A)STU X 902 ( 4.4A)NoneNoneNoneSTU X 902 (-4.1A)STU X 902 (-3.5A)NoneSTU X 902 ( 4.1A) | 0.59A | 3oxzA-2dq7X:32.4 | 3oxzA-2dq7X:44.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2dq7 | PROTO-ONCOGENETYROSINE-PROTEINKINASE FYN (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | GLU X 54MET X 58VAL X 67THR X 82HIS X 128ALA X 147ASP X 148 | STU X 902 ( 4.4A)NoneNoneSTU X 902 (-4.1A)NoneSTU X 902 ( 4.1A)STU X 902 (-3.6A) | 1.15A | 3oxzA-2dq7X:32.4 | 3oxzA-2dq7X:44.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2eu9 | DUAL SPECIFICITYPROTEIN KINASE CLK3 (Homo sapiens) |
PF00069(Pkinase) | 7 | ALA A 184GLU A 201ILE A 208VAL A 220GLY A 240HIS A 281ALA A 319 | None | 0.99A | 3oxzA-2eu9A:21.3 | 3oxzA-2eu9A:23.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2h8h | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC (Homo sapiens) |
PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 7 | ALA A 293LEU A 322VAL A 323THR A 338GLY A 344HIS A 384ALA A 403 | H8H A 534 (-3.2A)NoneNoneH8H A 534 (-3.1A)H8H A 534 (-3.3A)NoneH8H A 534 ( 4.0A) | 0.68A | 3oxzA-2h8hA:30.8 | 3oxzA-2h8hA:27.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2hck | HEMATOPOETIC CELLKINASE HCK (Homo sapiens) |
PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 7 | ALA A 293LEU A 322VAL A 323THR A 338GLY A 344HIS A 384ALA A 403 | QUE A 1 (-3.5A)NoneNoneQUE A 1 (-3.3A)QUE A 1 (-3.0A)NoneQUE A 1 ( 4.5A) | 0.65A | 3oxzA-2hckA:30.2 | 3oxzA-2hckA:32.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2hk5 | TYROSINE-PROTEINKINASE HCK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 9 | ALA A 271GLU A 288MET A 292LEU A 300VAL A 301THR A 316GLY A 322HIS A 362ALA A 381 | 1BM A 499 (-3.6A)1BM A 499 (-3.2A)1BM A 499 ( 3.8A)NoneNone1BM A 499 (-3.2A)1BM A 499 (-3.5A)None1BM A 499 ( 3.7A) | 0.72A | 3oxzA-2hk5A:27.3 | 3oxzA-2hk5A:46.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2hk5 | TYROSINE-PROTEINKINASE HCK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 8 | ALA A 271GLU A 288MET A 292VAL A 301THR A 316GLY A 322ALA A 381ASP A 382 | 1BM A 499 (-3.6A)1BM A 499 (-3.2A)1BM A 499 ( 3.8A)None1BM A 499 (-3.2A)1BM A 499 (-3.5A)1BM A 499 ( 3.7A)1BM A 499 (-4.4A) | 0.96A | 3oxzA-2hk5A:27.3 | 3oxzA-2hk5A:46.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2hz0 | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 11 | ALA A 269GLU A 286MET A 290ILE A 293LEU A 298VAL A 299THR A 315GLY A 321HIS A 361ALA A 380ASP A 381 | GIN A 600 (-3.1A)GIN A 600 (-3.6A)GIN A 600 (-3.2A)GIN A 600 (-4.5A)GIN A 600 (-4.2A)GIN A 600 (-4.6A)GIN A 600 (-3.4A)NoneGIN A 600 (-4.3A)GIN A 600 (-3.1A)GIN A 600 (-4.9A) | 0.76A | 3oxzA-2hz0A:34.3 | 3oxzA-2hz0A:99.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2j0j | FOCAL ADHESIONKINASE 1 (Gallus gallus) |
PF00373(FERM_M)PF07714(Pkinase_Tyr) | 7 | ALA A 452GLU A 471MET A 475VAL A 484GLY A 505HIS A 544ASP A 564 | 4ST A1687 (-3.3A)4ST A1687 ( 4.6A)NoneNone4ST A1687 (-3.2A)None4ST A1687 (-4.7A) | 0.84A | 3oxzA-2j0jA:32.7 | 3oxzA-2j0jA:19.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2jkm | FOCAL ADHESIONKINASE 1 (Gallus gallus) |
PF07714(Pkinase_Tyr) | 7 | ALA A 452GLU A 471MET A 475VAL A 484GLY A 505HIS A 544ASP A 564 | BII A1687 (-3.5A)NoneNoneNoneBII A1687 (-3.6A)NoneNone | 0.94A | 3oxzA-2jkmA:32.4 | 3oxzA-2jkmA:41.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2og8 | PROTO-ONCOGENETYROSINE-PROTEINKINASE LCK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 11 | ALA A 271GLU A 288MET A 292LEU A 300VAL A 301THR A 316GLY A 322HIS A 362ALA A 381ASP A 382PHE A 383 | 1N8 A 501 ( 3.4A)1N8 A 501 ( 3.6A)1N8 A 501 ( 3.6A)1N8 A 501 ( 3.9A)None1N8 A 501 ( 3.3A)1N8 A 501 ( 3.5A)None1N8 A 501 ( 3.3A)1N8 A 501 ( 3.3A)1N8 A 501 ( 4.3A) | 0.55A | 3oxzA-2og8A:32.1 | 3oxzA-2og8A:45.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ogv | MACROPHAGECOLONY-STIMULATINGFACTOR 1 RECEPTORPRECURSOR (Homo sapiens) |
PF07714(Pkinase_Tyr) | 8 | ALA A 614GLU A 633MET A 637VAL A 647THR A 663GLY A 669HIS A 776ASP A 796 | None | 0.84A | 3oxzA-2ogvA:21.4 | 3oxzA-2ogvA:37.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2p4i | ANGIOPOIETIN-1RECEPTOR (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 853GLY A 908HIS A 962ALA A 981ASP A 982PHE A 983 | MR9 A 301 (-3.5A)MR9 A 301 ( 3.8A)MR9 A 301 (-4.5A)MR9 A 301 (-3.2A)MR9 A 301 (-4.2A)MR9 A 301 (-4.4A) | 0.45A | 3oxzA-2p4iA:24.0 | 3oxzA-2p4iA:36.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2psq | FIBROBLAST GROWTHFACTOR RECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 515GLU A 534MET A 538ILE A 541GLY A 570HIS A 624ALA A 643 | None | 0.61A | 3oxzA-2psqA:32.3 | 3oxzA-2psqA:34.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qlu | ACTIVIN RECEPTORTYPE IIB (Homo sapiens) |
PF00069(Pkinase) | 6 | ALA A 215GLU A 230LEU A 244THR A 265GLY A 271ALA A 338 | ADE A 488 (-3.2A)NoneNoneADE A 488 (-4.3A)ADE A 488 ( 4.1A)None | 0.65A | 3oxzA-2qluA:25.0 | 3oxzA-2qluA:23.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qlu | ACTIVIN RECEPTORTYPE IIB (Homo sapiens) |
PF00069(Pkinase) | 6 | ALA A 215LEU A 244THR A 265GLY A 271HIS A 319ALA A 338 | ADE A 488 (-3.2A)NoneADE A 488 (-4.3A)ADE A 488 ( 4.1A)NoneNone | 0.50A | 3oxzA-2qluA:25.0 | 3oxzA-2qluA:23.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r2p | EPHRIN TYPE-ARECEPTOR 5 (Homo sapiens) |
PF07714(Pkinase_Tyr)PF14575(EphA2_TM) | 6 | ALA A 705GLU A 724MET A 728THR A 753GLY A 759HIS A 798 | None | 0.88A | 3oxzA-2r2pA:26.4 | 3oxzA-2r2pA:37.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r4b | RECEPTORTYROSINE-PROTEINKINASE ERBB-4 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 749LEU A 780VAL A 781THR A 796GLY A 802HIS A 841 | GW7 A 1 (-3.3A)NoneGW7 A 1 ( 4.7A)GW7 A 1 (-4.0A)GW7 A 1 (-3.6A)None | 0.88A | 3oxzA-2r4bA:29.5 | 3oxzA-2r4bA:37.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2xyu | EPHRIN TYPE-ARECEPTOR 4, (Mus musculus) |
PF07714(Pkinase_Tyr) | 6 | ALA A 651MET A 674THR A 699GLY A 705HIS A 744ASP A 764 | Q9G A1898 (-3.2A)Q9G A1898 (-3.9A)Q9G A1898 (-3.5A)Q9G A1898 ( 3.8A)NoneNone | 0.81A | 3oxzA-2xyuA:27.1 | 3oxzA-2xyuA:38.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z8c | INSULIN RECEPTOR (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A1028GLU A1047MET A1051VAL A1060GLY A1082HIS A1130 | S91 A 1 (-3.2A)NoneNoneNoneS91 A 1 (-3.3A)None | 0.81A | 3oxzA-2z8cA:29.2 | 3oxzA-2z8cA:39.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2zv7 | TYROSINE-PROTEINKINASE LYN (Mus musculus) |
PF07714(Pkinase_Tyr) | 8 | ALA A 273GLU A 290MET A 294LEU A 302VAL A 303THR A 319HIS A 365ASP A 385 | None | 1.15A | 3oxzA-2zv7A:26.2 | 3oxzA-2zv7A:46.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2zv7 | TYROSINE-PROTEINKINASE LYN (Mus musculus) |
PF07714(Pkinase_Tyr) | 8 | ALA A 273MET A 294LEU A 302VAL A 303THR A 319GLY A 325HIS A 365ALA A 384 | None | 0.74A | 3oxzA-2zv7A:26.2 | 3oxzA-2zv7A:46.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2zv7 | TYROSINE-PROTEINKINASE LYN (Mus musculus) |
PF07714(Pkinase_Tyr) | 8 | ALA A 273MET A 294LEU A 302VAL A 303THR A 319HIS A 365ALA A 384ASP A 385 | None | 1.05A | 3oxzA-2zv7A:26.2 | 3oxzA-2zv7A:46.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3b2t | FIBROBLAST GROWTHFACTOR RECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 515MET A 538ILE A 541GLY A 570HIS A 624ALA A 643 | M33 A1996 (-3.3A)NoneNoneM33 A1996 ( 4.8A)NoneNone | 0.69A | 3oxzA-3b2tA:26.2 | 3oxzA-3b2tA:40.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3c1x | HEPATOCYTE GROWTHFACTOR RECEPTOR (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A1108GLU A1127MET A1131GLY A1163HIS A1202ALA A1221ASP A1222 | CKK A1500 (-3.2A)CKK A1500 (-3.4A)CKK A1500 (-3.4A)CKK A1500 ( 4.5A)CKK A1500 (-4.2A)CKK A1500 (-3.4A)CKK A1500 (-4.5A) | 0.81A | 3oxzA-3c1xA:30.3 | 3oxzA-3c1xA:34.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3c4f | BASIC FIBROBLASTGROWTH FACTORRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 512GLU A 531MET A 535GLY A 567HIS A 621ALA A 640 | C4F A 1 (-3.3A)NoneC4F A 1 ( 3.7A)NoneNoneC4F A 1 (-3.6A) | 0.56A | 3oxzA-3c4fA:31.8 | 3oxzA-3c4fA:40.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3d7u | TYROSINE-PROTEINKINASE CSK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 8 | ALA A 220GLU A 236MET A 240LEU A 248VAL A 249THR A 266GLY A 272HIS A 312 | None | 0.54A | 3oxzA-3d7uA:26.9 | 3oxzA-3d7uA:44.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3d7u | TYROSINE-PROTEINKINASE CSK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | GLU A 236MET A 240LEU A 248VAL A 249THR A 266HIS A 312ASP A 332 | None | 1.15A | 3oxzA-3d7uA:26.9 | 3oxzA-3d7uA:44.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3dko | EPHRIN TYPE-ARECEPTOR 7 (Homo sapiens) |
PF07714(Pkinase_Tyr)PF14575(EphA2_TM) | 7 | ALA A 663GLU A 682MET A 686VAL A 695HIS A 756ASP A 776PHE A 777 | IHZ A1001 (-3.3A)IHZ A1001 (-3.8A)IHZ A1001 (-3.5A)IHZ A1001 ( 4.9A)IHZ A1001 ( 4.9A)IHZ A1001 (-4.8A)IHZ A1001 (-4.7A) | 0.74A | 3oxzA-3dkoA:30.9 | 3oxzA-3dkoA:37.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3dko | EPHRIN TYPE-ARECEPTOR 7 (Homo sapiens) |
PF07714(Pkinase_Tyr)PF14575(EphA2_TM) | 7 | ALA A 663MET A 686VAL A 695GLY A 717HIS A 756ASP A 776PHE A 777 | IHZ A1001 (-3.3A)IHZ A1001 (-3.5A)IHZ A1001 ( 4.9A)IHZ A1001 ( 3.9A)IHZ A1001 ( 4.9A)IHZ A1001 (-4.8A)IHZ A1001 (-4.7A) | 0.77A | 3oxzA-3dkoA:30.9 | 3oxzA-3dkoA:37.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3hng | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 859GLU A 878GLY A 915HIS A1020ASP A1040PHE A1041 | 8ST A2001 ( 3.8A)8ST A2001 (-3.7A)None8ST A2001 ( 4.8A)None8ST A2001 ( 3.7A) | 0.90A | 3oxzA-3hngA:31.5 | 3oxzA-3hngA:33.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3hng | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 859GLU A 878ILE A 885VAL A 892GLY A 915HIS A1020ASP A1040 | 8ST A2001 ( 3.8A)8ST A2001 (-3.7A)None8ST A2001 ( 4.7A)None8ST A2001 ( 4.8A)None | 0.82A | 3oxzA-3hngA:31.5 | 3oxzA-3hngA:33.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3iec | SERINE/THREONINE-PROTEIN KINASE MARK2 (Homo sapiens) |
PF00069(Pkinase)PF00627(UBA) | 7 | ALA A 80MET A 104VAL A 113GLY A 135HIS A 173ALA A 192ASP A 193 | None | 1.00A | 3oxzA-3iecA:22.2 | 3oxzA-3iecA:25.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3iec | SERINE/THREONINE-PROTEIN KINASE MARK2 (Homo sapiens) |
PF00069(Pkinase)PF00627(UBA) | 7 | GLU A 100MET A 104VAL A 113GLY A 135HIS A 173ALA A 192ASP A 193 | None | 1.24A | 3oxzA-3iecA:22.2 | 3oxzA-3iecA:25.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3kul | EPHRIN TYPE-ARECEPTOR 8 (Homo sapiens) |
PF07714(Pkinase_Tyr)PF14575(EphA2_TM) | 6 | ALA A 665GLU A 684MET A 688THR A 713GLY A 719HIS A 758 | NoneNoneNoneNoneGOL A 403 (-3.4A)None | 0.61A | 3oxzA-3kulA:31.7 | 3oxzA-3kulA:34.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mdy | BONE MORPHOGENETICPROTEIN RECEPTORTYPE-1B (Homo sapiens) |
PF07714(Pkinase_Tyr)PF08515(TGF_beta_GS) | 6 | ALA A 229GLU A 244THR A 279GLY A 285HIS A 330ALA A 349 | LDN A 1 (-3.6A)NoneLDN A 1 (-3.8A)LDN A 1 (-3.3A)NoneLDN A 1 ( 3.8A) | 0.66A | 3oxzA-3mdyA:25.4 | 3oxzA-3mdyA:27.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3my0 | SERINE/THREONINE-PROTEIN KINASE RECEPTORR3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 227THR A 277GLY A 283HIS A 328ALA A 347ASP A 348 | LDN A 600 (-3.2A)LDN A 600 (-4.0A)LDN A 600 (-3.3A)NoneLDN A 600 ( 3.8A)None | 0.74A | 3oxzA-3my0A:24.9 | 3oxzA-3my0A:28.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ppz | SERINE/THREONINE-PROTEIN KINASE CTR1 (Arabidopsisthaliana) |
PF07714(Pkinase_Tyr) | 7 | ALA A 576GLU A 596MET A 600VAL A 609THR A 625GLY A 631HIS A 674 | STU A 1 (-3.3A)NoneNoneNoneSTU A 1 (-4.1A)STU A 1 (-3.2A)None | 0.57A | 3oxzA-3ppzA:28.8 | 3oxzA-3ppzA:33.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3sxs | CYTOPLASMICTYROSINE-PROTEINKINASE BMX (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 443MET A 464LEU A 472VAL A 473THR A 489GLY A 495HIS A 534 | PP2 A 1 (-3.2A)PP2 A 1 ( 4.3A)NoneNonePP2 A 1 (-3.3A)PP2 A 1 ( 4.2A)None | 0.44A | 3oxzA-3sxsA:31.5 | 3oxzA-3sxsA:42.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3tt0 | BASIC FIBROBLASTGROWTH FACTORRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 512GLU A 531MET A 535GLY A 567HIS A 621ALA A 640 | 07J A 1 (-3.5A)07J A 1 (-3.8A)07J A 1 (-3.8A)07J A 1 (-3.7A)None07J A 1 (-3.2A) | 0.57A | 3oxzA-3tt0A:30.6 | 3oxzA-3tt0A:34.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3v5q | NT-3 GROWTH FACTORRECEPTOR (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 570GLU A 588VAL A 601GLY A 623HIS A 677ASP A 697PHE A 698 | 0F4 A 902 (-3.2A)0F4 A 902 (-3.6A)None0F4 A 902 (-3.4A)0F4 A 902 (-4.1A)None0F4 A 902 (-4.1A) | 0.91A | 3oxzA-3v5qA:28.6 | 3oxzA-3v5qA:36.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3vid | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 866GLU A 885ILE A 892GLY A 922HIS A1026ASP A1046 | 4TT A2001 (-3.5A)NoneNone4TT A2001 (-3.7A)NoneNone | 0.76A | 3oxzA-3vidA:30.3 | 3oxzA-3vidA:34.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3vid | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 866GLU A 885VAL A 899GLY A 922HIS A1026ASP A1046 | 4TT A2001 (-3.5A)NoneNone4TT A2001 (-3.7A)NoneNone | 0.65A | 3oxzA-3vidA:30.3 | 3oxzA-3vidA:34.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4agd | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 866GLU A 885ILE A 892VAL A 899GLY A 922HIS A1026ASP A1046 | B49 A2000 (-3.5A)NoneNoneB49 A2000 ( 4.6A)B49 A2000 ( 3.7A)NoneNone | 0.78A | 3oxzA-4agdA:31.8 | 3oxzA-4agdA:34.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bc6 | SERINE/THREONINE-PROTEIN KINASE 10 (Homo sapiens) |
PF00069(Pkinase) | 6 | ALA A 63GLU A 81VAL A 94GLY A 116HIS A 155ALA A 174 | XZN A1317 (-3.5A)XZN A1317 (-3.9A)XZN A1317 (-4.4A)XZN A1317 ( 3.7A)NoneXZN A1317 ( 4.3A) | 0.58A | 3oxzA-4bc6A:20.2 | 3oxzA-4bc6A:29.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ckr | EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 9 | ALA A 653GLU A 672MET A 676THR A 701GLY A 707HIS A 764ALA A 783ASP A 784PHE A 785 | DI1 A1000 (-3.6A)DI1 A1000 (-3.8A)DI1 A1000 (-3.6A)DI1 A1000 (-3.6A)NoneDI1 A1000 (-3.8A)DI1 A1000 (-3.7A)DI1 A1000 (-4.1A)DI1 A1000 (-4.5A) | 0.80A | 3oxzA-4ckrA:30.8 | 3oxzA-4ckrA:36.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4crs | SERINE/THREONINE-PROTEIN KINASE N2 (Homo sapiens) |
PF00069(Pkinase)PF00433(Pkinase_C) | 7 | ALA A 684GLU A 705LEU A 720VAL A 721GLY A 743ALA A 799ASP A 800 | AGS A1985 (-3.5A)NoneNoneNoneNoneAGS A1985 ( 4.5A)AGS A1985 ( 3.3A) | 1.10A | 3oxzA-4crsA:20.6 | 3oxzA-4crsA:26.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4f0g | SERINE/THREONINE-PROTEIN KINASE ROCO4 (Dictyosteliumdiscoideum) |
PF07714(Pkinase_Tyr) | 6 | ALA A1053GLU A1078VAL A1091GLY A1111HIS A1152ALA A1176 | None | 0.70A | 3oxzA-4f0gA:21.3 | 3oxzA-4f0gA:30.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4f4p | TYROSINE-PROTEINKINASE SYK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 400GLU A 420MET A 424VAL A 433GLY A 454HIS A 492 | 0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-3.5A)None | 0.81A | 3oxzA-4f4pA:31.1 | 3oxzA-4f4pA:41.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fr4 | SERINE/THREONINE-PROTEIN KINASE 32A (Homo sapiens) |
PF00069(Pkinase) | 6 | ALA A 50GLU A 71LEU A 83VAL A 84GLY A 106HIS A 144 | STU A 401 (-3.2A)NoneNoneNoneSTU A 401 ( 3.7A)None | 0.88A | 3oxzA-4fr4A:20.5 | 3oxzA-4fr4A:22.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hvi | TYROSINE-PROTEINKINASE JAK3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 853GLU A 871VAL A 884GLY A 908HIS A 947ALA A 966 | 19S A1201 (-3.3A)NoneNone19S A1201 ( 3.8A)None19S A1201 ( 4.1A) | 0.51A | 3oxzA-4hviA:25.3 | 3oxzA-4hviA:34.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4id7 | ACTIVATED CDC42KINASE 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 156GLU A 177LEU A 189THR A 205GLY A 211HIS A 250 | 1G0 A 401 (-3.6A)1G0 A 401 ( 4.5A)None1G0 A 401 (-3.2A)1G0 A 401 ( 4.5A)None | 0.79A | 3oxzA-4id7A:24.2 | 3oxzA-4id7A:38.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k11 | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC (Homo sapiens) |
PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 6 | ALA A 293LEU A 322VAL A 323GLY A 344HIS A 384ALA A 403 | 0J9 A 601 (-3.3A)NoneNone0J9 A 601 ( 4.1A)None0J9 A 601 (-3.5A) | 0.41A | 3oxzA-4k11A:30.6 | 3oxzA-4k11A:34.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k33 | FIBROBLAST GROWTHFACTOR RECEPTOR 3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | ALA A 506GLU A 525MET A 529ILE A 532GLY A 561HIS A 615ALA A 634 | ACP A 801 (-3.3A)ACP A 801 ( 4.8A)NoneNoneACP A 801 ( 4.6A)NoneNone | 0.80A | 3oxzA-4k33A:26.4 | 3oxzA-4k33A:36.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lg4 | SERINE/THREONINE-PROTEIN KINASE 3 (Homo sapiens) |
PF00069(Pkinase) | 7 | ALA A 54GLU A 70MET A 74VAL A 83GLY A 105HIS A 144ALA A 163 | GOL A 404 ( 3.1A)NoneNoneGOL A 403 (-4.1A)GOL A 404 (-3.6A)NoneGOL A 403 ( 3.0A) | 0.87A | 3oxzA-4lg4A:17.7 | 3oxzA-4lg4A:25.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lgg | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC (Gallus gallus) |
PF07714(Pkinase_Tyr) | 7 | ALA A 293MET A 314LEU A 322VAL A 323GLY A 344HIS A 384ALA A 403 | VGG A 601 (-3.5A)VGG A 601 ( 3.6A)NoneVGG A 601 ( 4.8A)VGG A 601 ( 3.2A)NoneVGG A 601 ( 4.2A) | 0.64A | 3oxzA-4lggA:30.3 | 3oxzA-4lggA:46.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o2z | MITOGEN-ACTIVATEDPROTEIN KINASE 3,PUTATIVE (Leishmaniadonovani) |
PF00069(Pkinase) | 6 | GLU A 94MET A 98LEU A 106THR A 130HIS A 173ASP A 193 | 046 A 401 (-3.7A)046 A 401 (-3.5A)046 A 401 ( 4.6A)046 A 401 (-4.0A)046 A 401 (-4.1A)046 A 401 (-4.3A) | 0.66A | 3oxzA-4o2zA:20.9 | 3oxzA-4o2zA:25.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o38 | CYCLIN-G-ASSOCIATEDKINASE (Homo sapiens) |
PF00069(Pkinase) | 7 | ALA A 67GLU A 85MET A 89VAL A 99THR A 123GLY A 128HIS A 171 | SIN A 401 ( 3.7A)NoneNoneNoneNoneSIN A 401 (-3.5A)None | 0.81A | 3oxzA-4o38A:19.4 | 3oxzA-4o38A:25.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o38 | CYCLIN-G-ASSOCIATEDKINASE (Homo sapiens) |
PF00069(Pkinase) | 7 | GLU A 85MET A 89VAL A 99THR A 123GLY A 128HIS A 171ASP A 191 | NoneNoneNoneNoneSIN A 401 (-3.5A)NoneNone | 1.10A | 3oxzA-4o38A:19.4 | 3oxzA-4o38A:25.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4rt7 | RECEPTOR-TYPETYROSINE-PROTEINKINASE FLT3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 642GLU A 661VAL A 675GLY A 697HIS A 809ASP A 829 | P30 A1001 (-3.4A)P30 A1001 (-3.6A)NoneP30 A1001 (-3.4A)P30 A1001 ( 4.3A)None | 0.54A | 3oxzA-4rt7A:27.3 | 3oxzA-4rt7A:31.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4rt7 | RECEPTOR-TYPETYROSINE-PROTEINKINASE FLT3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 642VAL A 675GLY A 697HIS A 809ASP A 829PHE A 830 | P30 A1001 (-3.4A)NoneP30 A1001 (-3.4A)P30 A1001 ( 4.3A)NoneP30 A1001 (-3.9A) | 0.82A | 3oxzA-4rt7A:27.3 | 3oxzA-4rt7A:31.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ueu | TYROSINE KINASE AS -A COMMON ANCESTOR OFSRC AND ABL (syntheticconstruct) |
PF07714(Pkinase_Tyr) | 9 | ALA A 35GLU A 52LEU A 64VAL A 65THR A 81GLY A 87HIS A 127ALA A 146ASP A 147 | ACP A1264 (-2.9A)NoneNoneNoneACP A1264 (-4.5A)ACP A1264 (-3.5A)NoneNoneNone | 0.92A | 3oxzA-4ueuA:32.2 | 3oxzA-4ueuA:64.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ueu | TYROSINE KINASE AS -A COMMON ANCESTOR OFSRC AND ABL (syntheticconstruct) |
PF07714(Pkinase_Tyr) | 9 | ALA A 35GLU A 52MET A 56LEU A 64THR A 81GLY A 87HIS A 127ALA A 146ASP A 147 | ACP A1264 (-2.9A)NoneNoneNoneACP A1264 (-4.5A)ACP A1264 (-3.5A)NoneNoneNone | 1.05A | 3oxzA-4ueuA:32.2 | 3oxzA-4ueuA:64.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4usf | STE20-LIKESERINE/THREONINE-PROTEIN KINASE (Homo sapiens) |
PF00069(Pkinase) | 6 | ALA A 61VAL A 92GLY A 114HIS A 153ALA A 172ASP A 173 | 6UI A 700 (-3.3A)None6UI A 700 ( 4.2A)None6UI A 700 ( 4.1A)None | 0.79A | 3oxzA-4usfA:23.6 | 3oxzA-4usfA:27.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wsq | AP2-ASSOCIATEDPROTEIN KINASE 1 (Homo sapiens) |
PF00069(Pkinase) | 6 | ALA A 72GLU A 90MET A 94VAL A 104GLY A 132HIS A 174 | KSA A 405 (-3.2A)NoneNoneNoneKSA A 405 (-3.5A)None | 0.79A | 3oxzA-4wsqA:22.7 | 3oxzA-4wsqA:23.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4xcu | FIBROBLAST GROWTHFACTOR RECEPTOR 4 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 501GLU A 520MET A 524GLY A 556HIS A 610ALA A 629 | 40M A1002 ( 4.1A)40M A1002 (-3.7A)40M A1002 (-3.8A)40M A1002 ( 3.7A)None40M A1002 (-3.0A) | 0.44A | 3oxzA-4xcuA:31.0 | 3oxzA-4xcuA:40.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4xey | TYROSINE-PROTEINKINASE ABL1 (Homo sapiens) |
no annotation | 9 | ALA B 288MET B 309ILE B 312LEU B 317VAL B 318THR B 334GLY B 340HIS B 380ALA B 399 | 1N1 B 601 (-3.5A)1N1 B 601 (-3.7A)NoneNone1N1 B 601 ( 4.3A)1N1 B 601 (-3.3A)1N1 B 601 (-3.5A)None1N1 B 601 (-3.5A) | 0.56A | 3oxzA-4xeyB:30.8 | 3oxzA-4xeyB:93.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4xi2 | TYROSINE-PROTEINKINASE BTK (Mus musculus) |
PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 6 | ALA A 428LEU A 457VAL A 458THR A 474GLY A 480HIS A 519 | None | 0.88A | 3oxzA-4xi2A:29.8 | 3oxzA-4xi2A:38.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4xuf | RECEPTOR-TYPETYROSINE-PROTEINKINASE FLT3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 642GLU A 661GLY A 697HIS A 809ASP A 829PHE A 830 | P30 A1001 (-3.5A)P30 A1001 (-3.1A)P30 A1001 (-3.5A)P30 A1001 (-4.4A)NoneP30 A1001 ( 4.1A) | 0.74A | 3oxzA-4xufA:31.7 | 3oxzA-4xufA:37.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4xuf | RECEPTOR-TYPETYROSINE-PROTEINKINASE FLT3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 642GLU A 661VAL A 675GLY A 697HIS A 809ASP A 829 | P30 A1001 (-3.5A)P30 A1001 (-3.1A)NoneP30 A1001 (-3.5A)P30 A1001 (-4.4A)None | 0.54A | 3oxzA-4xufA:31.7 | 3oxzA-4xufA:37.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4xuf | RECEPTOR-TYPETYROSINE-PROTEINKINASE FLT3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 642MET A 665VAL A 675GLY A 697HIS A 809ASP A 829 | P30 A1001 (-3.5A)P30 A1001 (-4.4A)NoneP30 A1001 (-3.5A)P30 A1001 (-4.4A)None | 0.91A | 3oxzA-4xufA:31.7 | 3oxzA-4xufA:37.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4y93 | NON-SPECIFICPROTEIN-TYROSINEKINASE,NON-SPECIFICPROTEIN-TYROSINEKINASE (Bos taurus) |
PF00169(PH)PF00779(BTK)PF07714(Pkinase_Tyr) | 6 | ALA A 428LEU A 457VAL A 458THR A 474GLY A 480HIS A 519 | 746 A 702 (-2.4A)NoneNone746 A 702 (-3.7A)746 A 702 (-3.6A)None | 0.55A | 3oxzA-4y93A:30.7 | 3oxzA-4y93A:29.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yff | SERINE/THREONINE-PROTEIN KINASE TNNI3K (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 488GLU A 509THR A 539GLY A 545HIS A 586ALA A 605 | 4CV A 801 (-3.5A)None4CV A 801 (-2.8A)4CV A 801 ( 4.0A)None4CV A 801 ( 3.9A) | 0.91A | 3oxzA-4yffA:20.2 | 3oxzA-4yffA:28.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a46 | FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 512GLU A 531MET A 535GLY A 567HIS A 621ALA A 640 | 38O A1769 (-3.6A)EDO A1766 (-4.1A)EDO A1766 (-3.5A)38O A1769 (-3.4A)NoneEDO A1766 ( 4.4A) | 0.41A | 3oxzA-5a46A:25.2 | 3oxzA-5a46A:36.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homo sapiens) |
PF00069(Pkinase)PF00627(UBA) | 6 | ALA A 83GLU A 103VAL A 116GLY A 138HIS A 176ALA A 195 | 5RC A4000 (-3.6A)NoneNone5RC A4000 (-3.3A)None5RC A4000 ( 3.9A) | 0.92A | 3oxzA-5es1A:22.1 | 3oxzA-5es1A:25.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5grn | PLATELET-DERIVEDGROWTH FACTORRECEPTOR ALPHA (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | ALA A 625GLU A 644GLY A 680HIS A 816ASP A 836PHE A 837 | 748 A1001 (-3.7A)748 A1001 (-3.3A)748 A1001 ( 4.0A)748 A1001 (-3.8A)748 A1001 (-4.8A)748 A1001 (-3.7A) | 0.89A | 3oxzA-5grnA:27.6 | 3oxzA-5grnA:34.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5grn | PLATELET-DERIVEDGROWTH FACTORRECEPTOR ALPHA (Homo sapiens) |
PF07714(Pkinase_Tyr) | 8 | ALA A 625GLU A 644MET A 648VAL A 658THR A 674GLY A 680HIS A 816ASP A 836 | 748 A1001 (-3.7A)748 A1001 (-3.3A)748 A1001 (-3.4A)748 A1001 ( 4.8A)748 A1001 (-3.2A)748 A1001 ( 4.0A)748 A1001 (-3.8A)748 A1001 (-4.8A) | 0.60A | 3oxzA-5grnA:27.6 | 3oxzA-5grnA:34.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hu3 | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II ALPHACHAIN (Drosophilamelanogaster) |
PF00069(Pkinase) | 7 | ALA A 41GLU A 61VAL A 74GLY A 96HIS A 134ALA A 156ASP A 157 | ADP A 301 (-3.5A)NoneNoneNoneNoneADP A 301 ( 4.8A) MG A 302 ( 3.3A) | 1.07A | 3oxzA-5hu3A:23.0 | 3oxzA-5hu3A:26.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j5t | MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE KINASE3 (Homo sapiens) |
PF00069(Pkinase) | 7 | ALA A 43GLU A 61MET A 65VAL A 74GLY A 96HIS A 134ALA A 153 | 6G2 A 901 (-3.2A)NoneNoneNone6G2 A 901 (-3.6A)None6G2 A 901 ( 4.2A) | 0.67A | 3oxzA-5j5tA:21.6 | 3oxzA-5j5tA:25.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5joq | LMO2184 PROTEIN (Listeriamonocytogenes) |
PF01497(Peripla_BP_2) | 6 | ILE A 37THR A 40GLY A 107ALA A 115ASP A 116PHE A 117 | None | 0.92A | 3oxzA-5joqA:undetectable | 3oxzA-5joqA:20.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kbr | SERINE/THREONINE-PROTEIN KINASE PAK 1 (Homo sapiens) |
PF00069(Pkinase) | 7 | ALA A 297GLU A 315MET A 319VAL A 328GLY A 350HIS A 387ASP A 407 | IPW A 601 (-3.5A)IPW A 601 (-3.9A)IPW A 601 (-4.1A)NoneIPW A 601 ( 3.8A)NoneNone | 1.10A | 3oxzA-5kbrA:22.2 | 3oxzA-5kbrA:24.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lpy | PROTEINBRASSINOSTEROIDINSENSITIVE 1 (Arabidopsisthaliana) |
PF00069(Pkinase) | 6 | ALA A 909GLU A 927LEU A 939VAL A 940GLY A 962HIS A1007 | ATP A1200 (-3.5A)NoneNoneNoneATP A1200 ( 4.0A)None | 0.70A | 3oxzA-5lpyA:22.5 | 3oxzA-5lpyA:29.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lpz | PROTEINBRASSINOSTEROIDINSENSITIVE 1 (Arabidopsisthaliana) |
PF00069(Pkinase) | 6 | ALA A 909GLU A 927LEU A 939VAL A 940GLY A 962HIS A1007 | ADP A1200 (-3.5A)NoneNoneNoneADP A1200 ( 4.0A)None | 0.67A | 3oxzA-5lpzA:22.6 | 3oxzA-5lpzA:29.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bql | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE KINASE 2 (Homo sapiens) |
no annotation | 6 | ALA A 192VAL A 249GLY A 273HIS A 310ALA A 329ASP A 330 | BI9 A 501 (-3.3A)NoneBI9 A 501 (-3.3A)NoneNH4 A 506 ( 3.7A)None | 0.88A | 3oxzA-6bqlA:21.7 | 3oxzA-6bqlA:16.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6c9d | SERINE/THREONINE-PROTEIN KINASEMARK1,SERINE/THREONINE-PROTEIN KINASEMARK1 (Homo sapiens) |
no annotation | 6 | ALA A 87GLU A 107MET A 111VAL A 120HIS A 180ALA A 199 | None | 0.81A | 3oxzA-6c9dA:21.1 | 3oxzA-6c9dA:14.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cmj | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE KINASE 2 (Homo sapiens) |
no annotation | 6 | ALA A 192GLU A 236VAL A 249GLY A 273HIS A 310ALA A 329 | F6J A 501 (-3.4A)F6J A 501 ( 4.7A)NoneF6J A 501 ( 3.7A)NoneF6J A 501 ( 4.0A) | 0.81A | 3oxzA-6cmjA:3.7 | 3oxzA-6cmjA:14.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cth | CONCANAVALIN A-LIKELECTIN PROTEINKINASE FAMILYPROTEIN (Theobroma cacao) |
no annotation | 6 | ALA A 296LEU A 326VAL A 327GLY A 349HIS A 391ASP A 411 | FE7 A 601 (-3.3A)NoneNoneFE7 A 601 ( 3.7A)None MG A 602 ( 2.6A) | 0.86A | 3oxzA-6cthA:22.0 | 3oxzA-6cthA:12.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3d | INTERLEUKIN-1RECEPTOR-ASSOCIATEDKINASE 4 (Homo sapiens) |
no annotation | 6 | ALA A 211LEU A 245VAL A 246GLY A 268HIS A 309ASP A 329 | CJT A 502 (-3.4A)NoneNoneCJT A 502 ( 4.3A)NoneCJT A 502 ( 4.0A) | 0.90A | 3oxzA-6f3dA:23.5 | 3oxzA-6f3dA:13.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fyl | DUAL SPECIFICITYPROTEIN KINASE CLK2 (Homo sapiens) |
no annotation | 7 | ALA A 191GLU A 208ILE A 215VAL A 227GLY A 247HIS A 288ASP A 327 | 3NG A 501 (-3.3A)3NG A 501 ( 4.9A)NoneNoneNoneNone3NG A 501 (-4.5A) | 1.22A | 3oxzA-6fylA:21.6 | 3oxzA-6fylA:undetectable |